Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia.
作者： Merav Bar , Brent L. Wood , Jerald P. Radich , Kristine C. Doney , Ann E. Woolfrey
DOI: 10.1155/2014/421723
关键词: Leukemia 、 Hazard ratio 、 Gastroenterology 、 Internal medicine 、 Retrospective cohort study 、 Pediatrics 、 Minimal residual disease 、 Flow cytometry 、 Confidence interval 、 Transplantation 、 Medicine 、 Risk of mortality
摘要: In this retrospective study, we evaluated the impact of pre- and posttransplant minimal residual disease (MRD) detected by multiparametric flow cytometry (MFC) on outcome in 160 …
hindawi.com
core.ac.uk参考文章(33)
O. Spinelli, B. Peruta, M. Tosi, V. Guerini, A. Salvi, M. C. Zanotti, E. Oldani, A. Grassi, T. Intermesoli, C. Mico, G. Rossi, P. Fabris, G. Lambertenghi-Deliliers, E. Angelucci, T. Barbui, R. Bassan, A. Rambaldi, Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia. Haematologica. ,vol. 92, pp. 612- 618 ,(2007) , 10.3324/HAEMATOL.10965
T.H. Terwey, T.M. Le Duc, P.G. Hemmati, P. le Coutre, M. Nagy, P. Martus, B. Dörken, R. Arnold, NIH-defined graft-versus-host disease and evidence for a potent graft-versus-leukemia effect in patients with acute lymphoblastic leukemia Annals of Oncology. ,vol. 24, pp. 1363- 1370 ,(2013) , 10.1093/ANNONC/MDS615
P Bader, J Hancock, H Kreyenberg, NJ Goulden, D Niethammer, A Oakhill, CG Steward, R Handgretinger, JF Beck, T Klingebiel, Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL Leukemia. ,vol. 16, pp. 1668- 1672 ,(2002) , 10.1038/SJ.LEU.2402552
Brent Wood, 9-color and 10-color flow cytometry in the clinical laboratory. Archives of Pathology & Laboratory Medicine. ,vol. 130, pp. 680- 690 ,(2006) , 10.1043/1543-2165(2006)130[680:CACFCI]2.0.CO;2
Elaine Coustan-Smith, Jose Sancho, Michael L. Hancock, James M. Boyett, Frederick G. Behm, Susana C. Raimondi, John T. Sandlund, Gaston K. Rivera, Jeffrey E. Rubnitz, Raul C. Ribeiro, Ching-Hon Pui, Dario Campana, Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood. ,vol. 96, pp. 2691- 2696 ,(2000) , 10.1182/BLOOD.V96.8.2691
Christopher J.C. Knechtli, Nicholas J. Goulden, Jeremy P. Hancock, Victoria L.G. Grandage, Emma L. Harris, Russell J. Garland, Claire G. Jones, Anthony W. Rowbottom, Linda P. Hunt, Ann F. Green, Emer Clarke, Alan W. Lankester, Jacqueline M. Cornish, Derwood H. Pamphilon, Colin G. Steward, Anthony Oakhill, Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia Blood. ,vol. 92, pp. 4072- 4079 ,(1998) , 10.1182/BLOOD.V92.11.4072
Mehmet Uzunel, Marie Jaksch, Jonas Mattsson, Olle Ringdén, Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia. British Journal of Haematology. ,vol. 122, pp. 788- 794 ,(2003) , 10.1046/J.1365-2141.2003.04495.X
Monika Brüggemann, Thorsten Raff, Michael Kneba, Has MRD monitoring superseded other prognostic factors in adult ALL Blood. ,vol. 120, pp. 4470- 4481 ,(2012) , 10.1182/BLOOD-2012-06-379040
Dario Campana, Should Minimal Residual Disease Monitoring in Acute Lymphoblastic Leukemia be Standard of Care Current Hematologic Malignancy Reports. ,vol. 7, pp. 170- 177 ,(2012) , 10.1007/S11899-012-0115-4
Michael N. Dworzak, Gertraud Fröschl, Dieter Printz, Georg Mann, Ulrike Pötschger, Nora Mühlegger, Gerhard Fritsch, Helmut Gadner, Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia Blood. ,vol. 99, pp. 1952- 1958 ,(2002) , 10.1182/BLOOD.V99.6.1952